ES2174492T3 - Sistema de administracion transdermica con escopolamina base como principio activo. - Google Patents

Sistema de administracion transdermica con escopolamina base como principio activo.

Info

Publication number
ES2174492T3
ES2174492T3 ES98946364T ES98946364T ES2174492T3 ES 2174492 T3 ES2174492 T3 ES 2174492T3 ES 98946364 T ES98946364 T ES 98946364T ES 98946364 T ES98946364 T ES 98946364T ES 2174492 T3 ES2174492 T3 ES 2174492T3
Authority
ES
Spain
Prior art keywords
active principle
layer
escopolamine
basic
transdermal administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98946364T
Other languages
English (en)
Inventor
Walter Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2174492T3 publication Critical patent/ES2174492T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Sistema de administración transdérmica con el principio activo escopolamina base, comprendiendo una capa superior flexible, impermeable al principio activo, una capa reservorio que contiene principio activo, una membrana de control, una capa adhesiva de contacto para la fi jación del sistema a la piel, así como una hoja protectora, asimismo impermeable al principio activo, que se retira antes de la aplicación, caracterizado por, { estar constituidas la capa reservorio y la capa adhesiva de contacto por un polímero base de silicona autoadhesivo resistente a las aminas, { estar constituida la membrana de control por un copolímero de etilenvinilacetato, y { estar presente la escopolamina base, al menos en la capa reservorio, parcialmente en forma cristalina.
ES98946364T 1997-09-04 1998-08-18 Sistema de administracion transdermica con escopolamina base como principio activo. Expired - Lifetime ES2174492T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19738643A DE19738643C2 (de) 1997-09-04 1997-09-04 Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ES2174492T3 true ES2174492T3 (es) 2002-11-01

Family

ID=7841162

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98946364T Expired - Lifetime ES2174492T3 (es) 1997-09-04 1998-08-18 Sistema de administracion transdermica con escopolamina base como principio activo.

Country Status (21)

Country Link
US (1) US6537571B1 (es)
EP (1) EP1011674B1 (es)
JP (1) JP3834202B2 (es)
KR (1) KR100549846B1 (es)
AT (1) ATE214606T1 (es)
AU (1) AU738009B2 (es)
CA (1) CA2300339C (es)
DE (2) DE19738643C2 (es)
DK (1) DK1011674T3 (es)
ES (1) ES2174492T3 (es)
HU (1) HUP0003480A3 (es)
ID (1) ID24266A (es)
IL (1) IL134418A (es)
NO (1) NO20000894D0 (es)
NZ (1) NZ502873A (es)
PL (1) PL339226A1 (es)
PT (1) PT1011674E (es)
SK (1) SK3052000A3 (es)
TR (1) TR200000407T2 (es)
WO (1) WO1999011265A1 (es)
ZA (1) ZA988052B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050013957A1 (en) * 2003-07-15 2005-01-20 Boris Leschinsky Disposable medical article with multiple adhesives for skin attachment
DE102004020463A1 (de) * 2004-04-26 2005-11-10 Grünenthal GmbH Wirkstoffabgabesystem aus einem wirkstoffhaltigen Pflaster und mindestens einem Wirkstoffabgaberegulierungsmittel
DE102004044578A1 (de) * 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
US20070010550A1 (en) * 2005-07-08 2007-01-11 The Board Of Regents Of The University Of Texas Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia
CA2643037C (en) * 2006-02-27 2014-08-05 Noven Pharmaceuticals, Inc. Compositions and methods for delivery of amino-functional drugs
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
KR101572721B1 (ko) 2013-10-14 2015-11-27 주식회사 엘지생활건강 히오신을 유효 성분으로 함유하는 피부 건조증 또는 피부 장벽 기능 개선용 조성물
AU2016247674A1 (en) * 2015-04-14 2017-10-19 Atossa Genetics Inc. Compositions and methods of treatment of breast disorders and estrogen-related disorders
WO2019002208A1 (en) * 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING SCOPOLAMINE AND A SILICONE-TYPE ACRYLIC HYBRID POLYMER
DE102018118507A1 (de) 2018-07-31 2020-02-06 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Scopolamin ohne Membran

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35474A (en) * 1862-06-03 Improved rocket-harpoon
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4655767A (en) * 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3908431A1 (de) * 1989-03-15 1990-09-27 Lohmann Therapie Syst Lts Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung
EP0671176B1 (en) 1993-09-30 2001-06-06 Takiron Co. Ltd. Percutaneously absorbable preparation
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
DE4438989C2 (de) * 1994-09-16 1999-02-25 Lohmann Therapie Syst Lts Scopolaminpflaster
AU1120097A (en) 1995-12-01 1997-06-27 Alza Corporation Improved method for preventing crystal formation in a dispersion of a liquid in a matrix

Also Published As

Publication number Publication date
HK1032194A1 (en) 2001-07-13
HUP0003480A3 (en) 2001-03-28
IL134418A0 (en) 2001-04-30
HUP0003480A2 (hu) 2001-02-28
ID24266A (id) 2000-07-13
ATE214606T1 (de) 2002-04-15
AU9343498A (en) 1999-03-22
EP1011674A1 (de) 2000-06-28
JP2001514226A (ja) 2001-09-11
PL339226A1 (en) 2000-12-04
ZA988052B (en) 1999-03-05
AU738009B2 (en) 2001-09-06
CA2300339C (en) 2007-07-17
US6537571B1 (en) 2003-03-25
PT1011674E (pt) 2002-08-30
EP1011674B1 (de) 2002-03-20
NO20000894L (no) 2000-02-23
DE19738643A1 (de) 1999-03-11
NZ502873A (en) 2001-07-27
TR200000407T2 (tr) 2000-08-21
DE19738643C2 (de) 2001-10-04
KR100549846B1 (ko) 2006-02-06
WO1999011265A1 (de) 1999-03-11
NO20000894D0 (no) 2000-02-23
IL134418A (en) 2004-02-19
DE59803454D1 (de) 2002-04-25
CA2300339A1 (en) 1999-03-11
DK1011674T3 (da) 2002-07-08
KR20010023647A (ko) 2001-03-26
SK3052000A3 (en) 2000-12-11
JP3834202B2 (ja) 2006-10-18

Similar Documents

Publication Publication Date Title
DK170434B1 (da) Fladeformigt terapeutisk system, fremgangsmåder til fremstilling deraf og anvendelse deraf
AR064268A1 (es) Sistema terapeutico transdermico para administracion del principio activo buprenorfina
ES2174492T3 (es) Sistema de administracion transdermica con escopolamina base como principio activo.
PT1524975E (pt) Sistema aperfeicoado de administracao transdermica para a administracao de rotigotina
AR046307A1 (es) Metodo de pretratamiento y sistema para mejorar la administracion transdermica de drogas
PT680325E (pt) Sistema terapeutico transdermico com galantamina como componente activo
ES2116572T3 (es) Parche para la administracion percutanea de sustancias de contenido quimicamente basico, farmaceuticamente eficaces y volatiles, y un metodo para su fabricacion.
AR026040A1 (es) Sistema terapeutico transdermal que contiene clorhidrato de tulobuterol para la administracion del broncodilatador tulobuterol a traves de la piel
NZ541807A (en) UV stable transdermal therapeutic plaster
DK1418951T3 (da) Transdermalt teraeutisk system (TTS) med fentanyl som aktiv bestanddel
AR093940A1 (es) Sistema de liberacion transdermica, metodo de preparacion
ES2442250T3 (es) Parche adhesivo
ES2386730T3 (es) Procedimiento de producción de un parche adhesivo
AR026038A1 (es) Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion
DE60309329D1 (de) Verbessertes transdermales abgabesystem
ES2241588T3 (es) Sistema terapeutico transdermico que contiene desoxipeganin.
DK1143938T3 (da) Transdermalt terapeutisk system med en selvklæbende matrix, der indeholder organiske syreadditionssalte af alkaloider af morphin- eller morphin-type
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron
ES2198584T3 (es) Parche para aplicacion transdermica de pergolid.
DK1284718T3 (da) Okklusivt transdermalt terapeutisk system med et ikke-okklusivt baglag
CN215273862U (zh) 一种硅凝胶愈合贴
AR029664A1 (es) Parche portador de estrngenos con reservorio de sustancia activa a base de etilcelulosa y un copolemero de etileno, acetato de vinilo y vinilpirrolidona
AR022956A1 (es) Sistema transdermal terapeutico y procedimiento para su fabricacion

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1011674

Country of ref document: ES